• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺神经内分泌肿瘤患者的异时性第二原发性恶性肿瘤:一项基于人群的关于发生率、危险因素及预后的研究

Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis.

作者信息

Hu Tulan, Wang Wei, He Chiyi

机构信息

Department of Gastroenterology, Yijishan Hospital of Wannan Medical College, Wuhu 241000, China.

出版信息

J Oncol. 2021 Oct 31;2021:1565089. doi: 10.1155/2021/1565089. eCollection 2021.

DOI:10.1155/2021/1565089
PMID:34754307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8572596/
Abstract

BACKGROUND

This study aimed to evaluate the risk factors of developing second primary malignancies (SPMs) among patients with pancreatic neuroendocrine neoplasms (pNENs) and the prognosis of pNENs patients with SPMs (pSPMs) using data from the Surveillance, Epidemiology, and End Results (SEER) database.

METHODS

Data from patients diagnosed with pNENs between 1988 and 2016 were extracted. A case-control study was conducted to investigate the risk factors of developing SPMs among patients with pNENs. Meanwhile, cox regression analysis was also conducted to obtain the independent prognostic factors in pSPMs.

RESULTS

Of 7,630 patients with pNENs, 326 developed SPMs. Patients with pNENs who had not undergone surgery and had been diagnosed in recent periods had a higher risk of developing SPMs. The following independent prognostic predictors for pSPMs were identified: age, latency period, SEER stage, radiotherapy, and surgery.

CONCLUSIONS

These findings may improve the surveillance of risk factors for developing SPMs in patients with pNENs and the prognostic risk factors in pSPMs.

摘要

背景

本研究旨在利用监测、流行病学和最终结果(SEER)数据库的数据,评估胰腺神经内分泌肿瘤(pNENs)患者发生第二原发性恶性肿瘤(SPMs)的风险因素以及pNENs合并SPMs(pSPMs)患者的预后情况。

方法

提取1988年至2016年间诊断为pNENs的患者数据。进行病例对照研究以调查pNENs患者发生SPMs的风险因素。同时,进行cox回归分析以获得pSPMs的独立预后因素。

结果

在7630例pNENs患者中,326例发生了SPMs。未接受手术且近期诊断的pNENs患者发生SPMs的风险更高。确定了以下pSPMs的独立预后预测因素:年龄、潜伏期、SEER分期、放疗和手术。

结论

这些发现可能会改善对pNENs患者发生SPMs的风险因素以及pSPMs的预后风险因素的监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/d29a6f0854aa/JO2021-1565089.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/779f687c68c7/JO2021-1565089.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/c19c5d42b61b/JO2021-1565089.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/43dccfe2ab9a/JO2021-1565089.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/d3d1e9821e82/JO2021-1565089.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/7ccb98b00d4b/JO2021-1565089.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/d29a6f0854aa/JO2021-1565089.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/779f687c68c7/JO2021-1565089.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/c19c5d42b61b/JO2021-1565089.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/43dccfe2ab9a/JO2021-1565089.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/d3d1e9821e82/JO2021-1565089.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/7ccb98b00d4b/JO2021-1565089.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ca/8572596/d29a6f0854aa/JO2021-1565089.006.jpg

相似文献

1
Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis.胰腺神经内分泌肿瘤患者的异时性第二原发性恶性肿瘤:一项基于人群的关于发生率、危险因素及预后的研究
J Oncol. 2021 Oct 31;2021:1565089. doi: 10.1155/2021/1565089. eCollection 2021.
2
The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.肺神经内分泌肿瘤患者的第二原发性恶性肿瘤风险:基于 SEER 数据库的人群研究。
Curr Probl Cancer. 2020 Dec;44(6):100613. doi: 10.1016/j.currproblcancer.2020.100613. Epub 2020 Jun 12.
3
Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.无功能性胰腺神经内分泌肿瘤的临床病理特征及手术治疗对肝转移患者预后的影响:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Comput Math Methods Med. 2022 May 12;2022:3689895. doi: 10.1155/2022/3689895. eCollection 2022.
4
Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma.胃腺癌患者第二原发性恶性肿瘤的发生率、风险和预后。
Sci Rep. 2024 Mar 8;14(1):5766. doi: 10.1038/s41598-024-56408-4.
5
The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries.放疗对继发性恶性肿瘤发病率的影响:美国 SEER 癌症登记处的泛癌研究。
Curr Oncol. 2021 Jan 8;28(1):301-316. doi: 10.3390/curroncol28010035.
6
Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.结直肠癌患者的第二原发恶性肿瘤:基于人群的分析。
Oncologist. 2020 Apr;25(4):e644-e650. doi: 10.1634/theoncologist.2019-0266. Epub 2020 Jan 14.
7
Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).胰腺神经内分泌肿瘤的预后因素和长期结果:Ki-67 指数对生存的影响大于疾病分期。西班牙国家肿瘤登记处(RGETNE)的丰富经验。
Neuroendocrinology. 2013;98(2):156-68. doi: 10.1159/000355152. Epub 2013 Sep 19.
8
Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors.功能并非胰腺神经内分泌肿瘤的独立预后因素。
World J Gastroenterol. 2020 Jul 7;26(25):3638-3649. doi: 10.3748/wjg.v26.i25.3638.
9
The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.原发性结肠癌和直肠癌诊断后第二原发性恶性肿瘤的发病特征:一项基于人群的研究。
PLoS One. 2015 Nov 16;10(11):e0143067. doi: 10.1371/journal.pone.0143067. eCollection 2015.
10
[Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].散发性胰腺神经内分泌肿瘤与1型多发性内分泌肿瘤相关胰腺神经内分泌肿瘤的临床特征比较
Zhonghua Yi Xue Za Zhi. 2022 Apr 12;102(14):1014-1019. doi: 10.3760/cma.j.cn112137-20210822-01906.

引用本文的文献

1
Clinical Data-CT Radiomics-Based Model for Predicting Prognosis of Patients with Gastrointestinal Pancreatic Neuroendocrine Neoplasms (GP-NENs).基于临床数据的 CT 影像组学模型预测胃肠胰腺神经内分泌肿瘤(GP-NENs)患者的预后。
Comput Math Methods Med. 2022 Aug 5;2022:4186305. doi: 10.1155/2022/4186305. eCollection 2022.

本文引用的文献

1
A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database.一种用于大细胞肺癌的列线图预后模型:来自监测、流行病学和最终结果数据库的分析
Transl Lung Cancer Res. 2021 Feb;10(2):622-635. doi: 10.21037/tlcr-19-517b.
2
Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.小唾液腺癌治疗后第二原发恶性肿瘤的风险:监测、流行病学和最终结果数据库分析。
Head Neck. 2021 Jun;43(6):1769-1779. doi: 10.1002/hed.26641. Epub 2021 Feb 15.
3
Clinicopathological features and prognostic analysis of 77 patients with multiple primary cancers.
77 例多原发癌患者的临床病理特征和预后分析。
J BUON. 2020 Jul-Aug;25(4):2110-2116.
4
Understanding the Management and Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors: A Clinician's Guide to a Complex Illness.理解分化良好的胰腺神经内分泌肿瘤的管理和治疗:临床医生应对复杂疾病的指南。
JCO Oncol Pract. 2020 Nov;16(11):720-728. doi: 10.1200/JCOOP.20.00010. Epub 2020 Oct 21.
5
Characteristics and Prognostic Factors of Metachronous Second Primary Upper Gastrointestinal Cancer.同时性第二原发上消化道癌的特征和预后因素。
J Surg Res. 2021 Feb;258:254-264. doi: 10.1016/j.jss.2020.08.075. Epub 2020 Oct 7.
6
Second primary malignancies among cancer patients.癌症患者中的第二原发性恶性肿瘤。
Ann Transl Med. 2020 May;8(10):638. doi: 10.21037/atm-20-2059.
7
The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.肺神经内分泌肿瘤患者的第二原发性恶性肿瘤风险:基于 SEER 数据库的人群研究。
Curr Probl Cancer. 2020 Dec;44(6):100613. doi: 10.1016/j.currproblcancer.2020.100613. Epub 2020 Jun 12.
8
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.胰腺神经内分泌肿瘤:血清标志物、分期和治疗的综述。
World J Gastroenterol. 2020 May 21;26(19):2305-2322. doi: 10.3748/wjg.v26.i19.2305.
9
Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis.治疗方式对髓母细胞瘤第二原发肿瘤发展和结局的影响:监测、流行病学和最终结果分析。
Pediatr Blood Cancer. 2020 Aug;67(8):e28373. doi: 10.1002/pbc.28373. Epub 2020 May 26.
10
Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations.设计(受限)平均生存时间终点的临床试验:实用考虑。
Clin Trials. 2020 Jun;17(3):285-294. doi: 10.1177/1740774520905563. Epub 2020 Feb 17.